Haoxi Health director files initial Form 3

Haoxi Health Technology Ltd director Su Changmao has filed an initial Form 3, which is the required statement of beneficial ownership for new insiders.

Accepted by SEC EDGAR 04/02/2026 - 08:47 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Haoxi Health Technology Ltd director Su Changmao has filed an initial Form 3, which is the required statement of beneficial ownership for new insiders. The filing does not report any stock transactions, share holdings, or derivative positions in the provided data for this reporting person.

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"initial statement of beneficial ownership for new insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"reportingPersons: [{ "name": "Su Changmao" }]"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Haoxi Health Technology (HAO) disclose in Su Changmao’s Form 3?

The Form 3 shows that Su Changmao is a director of Haoxi Health Technology Ltd. In the provided data, the filing does not report any stock transactions, share holdings, or derivative securities positions for this reporting person.

Were any Haoxi Health Technology (HAO) share transactions reported by Su Changmao?

No transactions are reported for Su Changmao in this Form 3 data. The transaction summary shows zero buys, zero sells, and no derivative exercises, indicating only an initial ownership statement with no trading activity disclosed.

Does Su Changmao’s Form 3 for Haoxi Health Technology (HAO) show any current holdings?

The provided Form 3 data does not list any share holdings or derivative positions for Su Changmao. The holdingEntries and derivativeSummary fields are zero or empty, so no specific ownership amounts appear in this excerpt.

What role does Su Changmao hold at Haoxi Health Technology (HAO) in this filing?

The Form 3 identifies Su Changmao as a director of Haoxi Health Technology Ltd. The officer fields are not marked, and the person is not shown as a ten percent owner in the provided structured data.

Why is a Form 3 important for Haoxi Health Technology (HAO) investors?

Form 3 is the initial beneficial ownership report required when someone becomes an insider, such as a director. It establishes a baseline for future Form 4 and Form 5 filings that will show any subsequent trading or changes in ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Su Changmao

(Last) (First) (Middle)

ROOM 902, UNIT 1, 9TH FLOOR

NO.6A CHAOYANGMENWAI STREET

(Street)

BEIJING BEIJING 100020

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Haoxi Health Technology Ltd [ HAO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Changmao Su	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)